Schizophrenia is not a death sentence, says Robert S Laitman, MD, from Bronx Westchester Medical Group and SARDAA. In part 2 of his podcast series with Consultant360, Dr Laitman explains how his approach to...
Dr Jessica Bartfield from Wake Forest Baptist Health discusses intermittent fasting and time-restricted eating, what patient populations benefit most, and how the diets affect other cardiometabolic risk.
...
Dawn M. Mussallem, DO, from Mayo Clinic Florida discusses breast cancer survivorship, what a treatment plan should look like, and the ASCO guidelines for integrative therapies.
Dr Saira Sheikh from University of North Carolina at Chapel Hill discusses the lack of diversity in Lupus clinical trials, the new ACR partnership aimed at increasing access to trials for minorities, the...
Dr Jean-Frederic Colombel from Mount Sinai Medical Center discusses clinical challenges in inflammatory bowel disease for 2019, the need for a multidisciplinary approach, and more.
Shane Crotty, PhD, from the La Jolla Institute for Immunology, talks about his discovery of the Tfh pathway and how it has affected the development of vaccines.
In the second installment of this 2-part podcast, Dr Jane K Dickinson of Teachers College, Columbia University discusses the key takeaways of her talk at the 2018 Cardiometabolic Risk Summit, “Language...
In the first installment of this 2-part podcast, Dr Jane K Dickinson of Teachers College, Columbia University, discusses the importance of using appropriate language when treating people who have diabetes,...
Andrea Richardson, from RAND Corporation, discusses her research on obesity and environmental health. Which environmental interventions are the most successful?
